Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Chemoradiotherapy With Raltitrexed for Rectal Cancer in Elderly
NCT02992886Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Sep 2016
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of raltitrexed in rectal cancer, sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Disease-Free Survival at 2 years. Started Sep 2016; status: completed.
02
Drugs
raltitrexed
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02992886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02992886.